Latest filing published 16 Dec 2021 for Marpai, Inc., €19k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -82.7%Entry US$18.56 · Close at T+365 US$3.22
- -5.9%Entry US$40.50 · Close at T+365 US$38.10
- -13.0%Entry US$43.80 · Close at T+365 US$38.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Yoram Bibring: trading record in brief
This profile gathers the share dealings of Yoram Bibring across 2 companies, led by Brainstorm Cell Therapeutics Inc. and Marpai, Inc. Over a trading history stretching from 17 August 2015 to 15 December 2021, the count stands at 3 filings.
On the market, this insider has only ever bought: 3 purchases, €152k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2021 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €23k. After 3 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -11.6%. These figures describe past trades and do not predict future prices.
The newest entry dates from 16 December 2021: an open-market purchase of €19k, in Marpai, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Yoram Bibring
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$4.33100.0% of flowClass A Common StockSEC:0001104659-21-150302:0Canonical exit: 15 Mar 2022 (T+90)
- 8,500 shares@ US$3.04Common StockSEC:0001144204-15-051169:0Canonical exit: 18 Nov 2015 (T+90)
- 41,500 shares@ US$2.92Common StockSEC:0001144204-15-050518:0Canonical exit: 15 Nov 2015 (T+90)
3 of 3 declarations
